phase readout

NCT06821503: Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

RECRUITINGupdated 1mo ago

community read0 votes

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Advanced Pancreatic Cancer

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 24m ago

Found something off?